These reviewed findings, combined with prior studies, indicate that urinary MCP-1 seems to be a decent marker for active, inflammatory kidney disease and might also help to monitor treatment responses [39].Other markers might be more suited to the correct diagnosis of specific CKD etiologies or progress predictions than MCP-1. Here, CCL2 is linked to chronic kidney disease.